Combination Chemotherapy Plus Bevacizumab With or Without Oxaliplatin in Treating Older Patients With Metastatic Colorectal Cancer

NCT01279681 · clinicaltrials.gov ↗

PHASE3

Phase

TERMINATED

Status

32

Enrollment

OTHER

Sponsor class

Stopped Slow accrual

Conditions

Cognitive/Functional Effects
Colorectal Cancer
Neurotoxicity

Interventions

BIOLOGICAL: bevacizumab
DRUG: capecitabine
DRUG: fluorouracil
DRUG: leucovorin calcium
DRUG: oxaliplatin

Sponsor

Alliance for Clinical Trials in Oncology

Collaborators

[object Object]
[object Object]